Morderna’s publicly discussing its vaccine being 94.5% effective in trials. So we have efficacy for the first two vaccines out of the gate, now just waiting on the safety data. We’re going to break a quarter-million American deaths due to the plague at some point this week, so these vaccines couldn’t get here fast enough.

Up next is emergency use authorization, which the FDA will obviously grant, followed by news from AstraZeneca and Johnson & Johnson about their vaccines. We’ll have a billion vaccine doses in the first half of next year to eliminate this f***ing thing from our lives. I’m gonna see a Bruce Springsteen show for the first time when this is over. I’d always been meaning to get around to it, just never have.

Anyway, long-term investors who’ve been able to tune out the macro medicine shows and Twitter daytrading gurus are reaping the rewards of their tenacity. Portfolio values will soon be echoing the record highs being printed in the major averages this morning. You don’t get those record portfolio value highs if you’ve been churning your accounts to butter over every twist and turn in the economic data. You can keep the butter, I guess.

The vaccine(s) came at an all-time high. Stocks had been rallying in anticipation and then the Pfizer news sprung from the top of the stage, like the deus ex machina we knew it would be. We’re getting vaccine news at record stock market highs, not at lows.

As I explained on the podcast this weekend, one of the toughest concepts for investors to wrap their heads around is the fact that stocks could be falling amid positive news and rising while negatives dominate the headlines. This is because the buyers and sellers are thinking about tomorrow and what will happen, not what just happened or even necessarily what’s happening now.

Looking forward, we’re going to get our lives back and the expansion’s now seeming like it’ll remain intact while the shots are administered.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here:

Please see disclosures here.